A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.

Discover how Imaris 11 streamlines image analysis with automated workflows, reproducibility tools, and powerful batch processing.

Cancer is often difficult to detect in its early stages. Biomarkers that can reveal the disease are present only in very small amounts in the blood. As a result, many tests today require additional ...

Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) ...

Novartis has jettisoned an anti-cancer protein from its pipeline after the molecule failed to shrink tumors in 30 patients with advanced disease. The pharma giant halted the phase 1 trial of QEQ278 ...

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes.